104 related articles for article (PubMed ID: 14638970)
1. CSF hypocretin-1 levels in restless legs syndrome.
Stiasny-Kolster K; Mignot E; Ling L; Möller JC; Cassel W; Oertel WH
Neurology; 2003 Nov; 61(10):1426-9. PubMed ID: 14638970
[TBL] [Abstract][Full Text] [Related]
2. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome.
Allen RP; Mignot E; Ripley B; Nishino S; Earley CJ
Neurology; 2002 Aug; 59(4):639-41. PubMed ID: 12196669
[TBL] [Abstract][Full Text] [Related]
3. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
4. CSF hypocretin measures in patients with obstructive sleep apnea.
Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
[TBL] [Abstract][Full Text] [Related]
5. Circadian variation of hypocretin-1 (orexin A) in restless legs syndrome.
Baier PC; Göder R; Hallschmid M
Sleep Med; 2009 Feb; 10(2):271; author reply 272. PubMed ID: 19013101
[No Abstract] [Full Text] [Related]
6. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
[TBL] [Abstract][Full Text] [Related]
7. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats.
Yoshida Y; Fujiki N; Maki RA; Schwarz D; Nishino S
Neurosci Lett; 2003 Aug; 346(3):182-6. PubMed ID: 12853114
[TBL] [Abstract][Full Text] [Related]
8. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.
Nishino S; Kanbayashi T; Fujiki N; Uchino M; Ripley B; Watanabe M; Lammers GJ; Ishiguro H; Shoji S; Nishida Y; Overeem S; Toyoshima I; Yoshida Y; Shimizu T; Taheri S; Mignot E
Neurology; 2003 Sep; 61(6):823-5. PubMed ID: 14504329
[TBL] [Abstract][Full Text] [Related]
9. CSF hypocretin (Orexin) in neurological and psychiatric conditions.
Ebrahim IO; Semra YK; De Lacy S; Howard RS; Kopelman MD; Williams A; Sharief MK
J Sleep Res; 2003 Mar; 12(1):83-4. PubMed ID: 12603790
[No Abstract] [Full Text] [Related]
10. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation.
Fujiki N; Yoshida Y; Ripley B; Honda K; Mignot E; Nishino S
Neuroreport; 2001 Apr; 12(5):993-7. PubMed ID: 11303775
[TBL] [Abstract][Full Text] [Related]
11. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.
Ripley B; Overeem S; Fujiki N; Nevsimalova S; Uchino M; Yesavage J; Di Monte D; Dohi K; Melberg A; Lammers GJ; Nishida Y; Roelandse FW; Hungs M; Mignot E; Nishino S
Neurology; 2001 Dec; 57(12):2253-8. PubMed ID: 11756606
[TBL] [Abstract][Full Text] [Related]
12. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture.
Nishino S; Ripley B; Mignot E; Benson KL; Zarcone VP
Psychiatry Res; 2002 May; 110(1):1-7. PubMed ID: 12007588
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.
Kanbayashi T; Yano T; Ishiguro H; Kawanishi K; Chiba S; Aizawa R; Sawaishi Y; Hirota K; Nishino S; Shimizu T
Sleep; 2002 May; 25(3):337-9. PubMed ID: 12003164
[TBL] [Abstract][Full Text] [Related]
14. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes.
Earley CJ; Connor JR; Beard JL; Clardy SL; Allen RP
Sleep; 2005 Sep; 28(9):1069-75. PubMed ID: 16268375
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
16. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
17. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.
Overeem S; Dalmau J; Bataller L; Nishino S; Mignot E; Verschuuren J; Lammers GJ
Neurology; 2004 Jan; 62(1):138-40. PubMed ID: 14718718
[TBL] [Abstract][Full Text] [Related]
19. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release.
Zhang S; Zeitzer JM; Yoshida Y; Wisor JP; Nishino S; Edgar DM; Mignot E
Sleep; 2004 Jun; 27(4):619-27. PubMed ID: 15282996
[TBL] [Abstract][Full Text] [Related]
20. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor.
Arii J; Kanbayashi T; Tanabe Y; Ono J; Nishino S; Kohno Y
Neurology; 2001 Jun; 56(12):1775-6. PubMed ID: 11425955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
